8-K 1 c86065e8vk.txt FORM 8-K -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------------------------------------------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2004 SYNOVIS LIFE TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) State of Incorporation: Minnesota I.R.S. Employer Identification No.: 41-1526554 Address of principal executive offices: 2575 University Ave. W. St. Paul, Minnesota 55114 Telephone Number: (651) 796-7300 --------------------------------------------------- Item 5. Other Events and Regulation FD Disclosure. On June 7, 2004, Synovis Life Technologies, Inc. ("Synovis" or the "Company") issued a press release expressing sympathy on the death of Anton R. Potami, a board member of the Company. A copy of the press release is attached hereto as Exhibit 99.1. Synovis has also published the press release, including the supplemental information contained therein, on its website www.synovislife.com. Item 7. Financial Statements and Exhibits. (c) Exhibits. (99.1) Synovis Life Technologies, Inc. News Release dated June 7, 2004.
SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SYNOVIS LIFE TECHNOLOGIES, INC. By: /s/ Connie L. Magnuson ------------------------------ June 9, 2004 Connie L. Magnuson Vice-President of Finance and Chief Financial Officer 2